Discovery of a selective inhibitor for the YEATS domains of ENL/AF9
Eleven-nineteen leukemia (ENL) contains an epigenetic reader domain (YEATS domain) that recognizes lysine acylation on histone 3 and facilitates transcription initiation and elongation through its interactions with the super elongation complex (SEC) and the histone methyl transferase DOT1L. Although...
Main Authors: | Christott, T, Bennett, J, Coxon, C, Monteiro, O, Giroud, C, Beke, V, Felce, S, Gamble, V, Gileadi, C, Poda, G, Al-Awar, R, Farnie, G, Fedorov, O |
---|---|
Format: | Journal article |
Language: | English |
Published: |
SAGE Publications
2018
|
Similar Items
-
Discovery of an MLLT1/3 YEATS domain chemical probe
by: Moustakim, M, et al.
Published: (2018) -
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
by: Leopold Garnar-Wortzel, et al.
Published: (2021-04-01) -
Transcription control by the ENL YEATS domain in acute leukaemia
by: Erb, Michael A., et al.
Published: (2017) -
Fragment-Based Discovery of AF9 YEATS Domain Inhibitors
by: Yaqian Liu, et al.
Published: (2022-03-01) -
Structural insights into interaction mechanisms of alternative piperazine-urea YEATS domain binders in MLLT1
by: Ni, X, et al.
Published: (2019)